1. Home
  2. FINV vs ZVRA Comparison

FINV vs ZVRA Comparison

Compare FINV & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinVolution Group

FINV

FinVolution Group

HOLD

Current Price

$3.07

Market Cap

739.0M

Sector

Finance

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$11.30

Market Cap

689.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FINV
ZVRA
Founded
2007
2006
Country
China
United States
Employees
3869
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
739.0M
689.4M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
FINV
ZVRA
Price
$3.07
$11.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$12.10
★ $23.00
AVG Volume (30 Days)
★ 1.0M
774.2K
Earning Date
05-19-2026
05-06-2026
Dividend Yield
★ 6.09%
N/A
EPS Growth
N/A
★ 159.21
EPS
N/A
★ 0.74
Revenue
N/A
★ $106,470,000.00
Revenue This Year
N/A
$37.27
Revenue Next Year
$10.58
$53.42
P/E Ratio
★ $3.87
$14.93
Revenue Growth
N/A
★ 350.91
52 Week Low
$3.10
$8.01
52 Week High
$7.65
$15.04

Technical Indicators

Market Signals
Indicator
FINV
ZVRA
Relative Strength Index (RSI) 27.40 39.00
Support Level N/A $10.81
Resistance Level $3.49 $12.19
Average True Range (ATR) 0.11 0.40
MACD 0.02 -0.11
Stochastic Oscillator 10.47 12.54

Price Performance

Historical Comparison
FINV
ZVRA

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: